Schedule (updated 6/6/07)
Saturday, Sunday, Monday, Tuesday
Saturday July 14th, 2007
Joint NCL Congress and BDSRA session on Therapeutic approaches
1PM- 5PM
Welcoming remarks: David Pearce, University of Rochester Medical Center, USA
Session I: Therapeutic approaches for the NCLs
Chairs: David Pearce and Jane Emanuel
Plenary Lecture
Steven Goldman, University of Rochester Medical Center, USA
Stem Cells
NCL Plenary Lecture
Beverly Davidson, University of Iowa College of Medicine, USA
Approaching wide-spread enzyme replacement in patients with TPP-1 deficiency.
Invited Speakers
Robert Steiner, Oregon Health Science Center, USA
A Phase 1 Clinical Study of Human CNS Stem Cells (HuCNS-SC) in Patients with Neuronal Ceroid Lipofuscinosis
Ronald Crystal, Weill Cornell Medical College, USA
Adeno-associated Viral-mediated Gene Therapy for the CNS Manifestations of Batten Disease
Break
NCL presentations chosen from submitted abstracts.
Michael Chang, University of Iowa College of Medicine, USA - Intraventricular enzyme replacement in a mouse model of late infantile neuronal ceroid lipofuscinosis
Atilla Kovacs, University of Rochester Medical Center, USA - Effects of EGIS-8332, a non-competitive AMPA receptor antagonist, on the motor skills of Cln3-knockout mice
Laura Åberg, Helsinki University Central Hospital, Finland - Autoantibodies to GAD65 and intermittent prednisolone in juvenile neuronal ceroid lipofuscinosis
David Pearce, University of Rochester Medical Center, USA - Phenotypic amelioration of a behavioral deficit in Cln3-/- mice by immunosuppression
Krystyna Wisniewski, NYS Institute of Basic Research, USA - Clinical Trial: Cystagon to Treat Infantile Neuronal Ceroid Lipofuscinosis with Late Infantile and Juvenile Onset
Open Discussion
Welcome reception and attendance of BDSRA Banquet
Sunday July 15th, 2007
NCL Congress
8:30AM- 12:30PM
Welcoming remarks: David Pearce, University of Rochester Medical Center
Session II: Infantile NCL and CLN1
Chair: Beverly Davidson
Plenary Lecture
Maiken Nedergaard, University of Rochester Medical Center, USA -
Astrocytes as active participants in brain function
NCL Plenary Lecture
Sandra Hoffman, University of Texas Southwestern, USA
Palmitoyl-Protein Thioesterase and the Molecular Basis of Infantile NCL
Invited Speakers
Anu Jalanko, National Public Health Institute, Finland
Mouse Ppt1 deficiency is linked to defects in fundamental cellular processes
Mark Sands, Washington University School of Medicine, USA - Systemic and metabolic abnormalities associated with murine Infantile Neuronal Ceroid Lipofuscinosis
Break
NCL presentations chosen from submitted abstracts.
Annina Lyly, National Public Health Institute, Finland - Novel interacting partner of palmitoyl protein thioesterase 1 links PPT1 to lipid metabolism
Catherine Kielar, Institute of Psychiatry, King’s College London, United Kingdom - Pathological involvement of the thalamus in mouse models of NCL extends to non-sensory relay nuclei
Chris Korey, College of Charleston, USA - Genetic and Cell Biological Approaches to Characterizing Ppt1 Function in Drosophila
Poster Session I
Lunch
Sunday July 15th, 2007
NCL Congress
1:30PM- 5PM
Session III: Late-Infantile NCL and CLN2
Chair: Jonathan Cooper
Plenary Lecture
Michael Brenner, University of Alabama at Birmingham, USA
Alexander disease: a genetic disorder of astrocytes
NCL Plenary Lecture
David Sleat, Center for Advanced Biotechnology and Medicine, University of Medicine and Dentistry of New Jersey, USA
Lysosomal proteomics and human disease.
Invited Speakers
David Sleat, Center for Advanced Biotechnology and Medicine, University of Medicine and Dentistry of New Jersey, USA
Rescuing the LINCL phenotype in CLN2 mutant mice
Adam Golabek, Institution for Basic Research, Staten Island, USA
The role of prosegment in TPP I activity and stability
Joan Coates, College of Veterinary Medicine, University of Missouri-Columbia, USA
Phenotypic characterization of a Dachshund model for CLN2
Poster Session II - Presenters will be with posters
Dinner
Workshop
Clinical Scientists – Organizer Jonathan Mink
Monday July 16th, 2007
NCL Congress
8:30AM- 12:30PM
Session IV: Juvenile-NCL
Chair: Sandra Hoffman
Plenary Lecture
Kirill Kiselyov, University of Pittsburgh, USA
Lysosomal deficiencies and cell death in mucolipidosis type IV.
NCL Plenary Lecture
David Pearce, University of Rochester Medical Center, USA
JNCL and CLN3
Invited Speakers
Colleen Stein, University of Iowa College of Medicine, USA
Osmoregulation of CLN3 in the Renal Medulla
NCL presentations chosen from submitted abstracts.
Steven Eliason, University of Iowa College of Medicine, USA - A Knock-In Reporter Model of Batten’s Disease
Break
Denia Ramirez-Montealegre, University of Rochester Medical Center, USA - Arginine Defects in JNCL: Implications for Nitric Oxide Production
Nuno Osorio, Universidade do Minho Campus de Gualtar, Portugal - Arginine related nitric oxide synthesis defect in btn1-?: possible implications for JNCL pathogenesis
Stephan Storch/ S. Pohl, Universitätskrankenhaus Eppendorf, Germany - Up-regulation of lysosomal acid phosphatase (ACP2) in CLN3-deficient cells and Cln3 -/- mouse brain
Jared Benedict, University of Rochester Medical Center, USA - Loss of a CLN3 protein interaction may lead to specific cerebellar phenotypes in the Cln3-/- mouse
Srinivas Narayan, Children’s Hospital of Philadelphia, USA - Palmitoyl-protein desaturase activity demonstrates intermediate activity in neuronal tissues from heterozygote cln3 knockout mice
Hannah Mitchinson, University College London, United Kingdom - Dysfunction of autophagic and endocytic pathways in Batten disease (CLN3)
Lunch
Monday July 16th, 2007
NCL Congress
1:30PM- 6:00PM
Session V: Common Themes and NCL Comparisons Chair: Glyn Dawson
Plenary Lecture
Steven Walkley, Albert Einstein College of Medicine, USA
Thinking “Outside the Organelle” to Understand Lysosomal Disease
NCL Plenary Lecture
Jonathan Cooper, Kings College, London, United Kingdom
Common themes in mouse models of NCL?
Invited Speakers
Susan Cotman, Harvard Medical School, USA
Cln3 and Cln6 disease mutations cause similar yet distinct phenotypes in mice and in cultured cells
Sara Mole, University College London, United Kingdom
Re-interpretation of the genotype-phenotype correlations in Batten disease are changing our perspective of the disease
Break
NCL presentations chosen from submitted abstracts
Rose-Mary Boustany, Duke University Medical Center, USA - NCL: A Common Pathway
Taina Autti, Helsinki University Hospital – Rontgen, Finland - T2 and T1 -weighted images, proton density images and FLAIR images show abnormal signal intensity in CLN1, CLN3 and CLN 5
Elena Rusyn, Duke University Medical Center, USA - Altered NCL lipid raft morphology and sphingolipids
Claire Russell, University College London, United Kingdom - Generation of zebrafish models of Neuronal Ceroid Lipofuscinosis
Elina Maaranen, National Public Health Institute, Helsinki, Finland - Comparison of gene expression patterns of Cln1, Cln3, Cln5 and Cln8 deficient mouse models
Poster Session III
Dinner on your own
Workshops
Batten Foundation Presentations – Organizer, Frank Stehr
Rare NCL Gene Consortium – Organizer, Sara Mole
Tuesday July 17th, 2007
NCL Congress
9AM- 12:30PM
Session VI: CLN3 – Chair: Anu Jalanko
Plenary Lecture
William Gahl, National Institutes of Health, USA
Cystinosis
NCL presentations chosen from submitted abstracts.
Sergio Padilla-Lopez, University of Rochester Medical Center, USA - Evidences for Btn1p as an uncoupler of the vacuolar ATPase complex in Saccharomyces cerevisiae
Rebecca Haines, University College London, United Kingdom - Identifying functional domains of btn1, the Schizosaccharomyces pombe orthologue to the juvenile NCL gene CLN3
Stephan Storch, Universitätskrankenhaus Eppendorf, Germany - C-terminal prenylation of the CLN3 membrane glycoprotein is required for efficient endosomal sorting to lysosomes
Break
Mika Ruonala, European Neuroscience Institute, Germany - Getting a grip of CLN3
Seasson Phillips-Vitiello, University of Rochester Medical Center, USA - Identification of an evolutionarily conserved protein interaction with CLN3
Claudia Kitzmuller, University College London, United Kingdom - CLN3 is involved in cytoskeletal organisation
Kristiina Yliannala, National Public Health Institute, Finland - Novel interactions of JNCL protein CLN3: Implications for function in plasma membrane association of Na+, K+ ATPase
Richard Tuxworth, Kings College of London, United Kingdom - Drosophila as a model system for understanding Cln3 cell biology
Lunch
Tuesday July 17th, 2007
NCL Congress
1:00PM- 5:30PM
Session VII: Variant NCLs, CTSD, CLN5, CLN6, CLN7, CLN8, and CLN9
Chair: Mark Sands
Plenary Lecture
Jaana Tyynela, University of Helsinki, Finland
Cathepsin D deficiencies
Invited Speakers
Thomas Braulke, University of Hamburg, Germany
Analysis of pathomechanisms in NCL mouse models
David Palmer, Lincoln University, New Zealand
Studies Towards Anti-inflammatory and Gene Therapy in Ovine Batten Disease
Peter Houweling, University of Sydney, Australia
Four large animal models of the Neuronal Ceroid Lipofuscinoses CLN5 & CLN6
Break
NCL presentations chosen from submitted abstracts.
Robert Steinfeld, University of Göttingen, Germany - Partial cathepsin D deficiency is associated with juvenile and adult neuronal ceroid lipofuscinosis
Romina Kohan, Center for the Study of Inborn Errors of Metabolism (CEMECO) Children’s Hospital, National University of Cordoba, Argentina - First CLN5 mutations in Argentina
Carlos Bessa, Instituto Genetica Medica, Unidade de Enzimologia, Portugal - The CLN5 protein defective in the Finnish vLINCL is a junctional plasma membrane protein
Aija Kyttala, National Public Health Institute, Finland - CLN5- A link for common molecular pathways underlying neuronal ceroid lipofuscinosis?
Carina von Schantz, National Public Health Institute, Finland - Progressive neuron loss in the thalamocortical system of Cln5 deficient mice: evidence for distinct effects in Finnish variant late infantile NCL
Arne Quitsch, University of Hamburg, Germany - Functional analysis of the down regulation of GABAAa2 receptor subunits in the brain of nclf-mice
Jared Benedict, University of Rochester Medical Center, USA - The ER resident protein CLN6 interacts with a protein involved in axon guidance
Eija Siintola, Folkhälsan Institute of Genetics, Finland - The novel neuronal ceroid lipofuscinosis gene CLN7 encodes a putative lysosomal transporter protein
Rose-Mary Boustany, Duke University Medical Center, USA - In Search of the CLN9 gene and Protein
5:15PM – 6:00PM
Conference Wrap Up/Discussion
Banquet